Literature DB >> 17202583

A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.

Theodora Szasz1, Keshari Thakali, Gregory D Fink, Stephanie W Watts.   

Abstract

Reactive oxygen species (ROS) are by-products of oxygen metabolism, normally present in low levels inside cells, where they participate in signaling processes. The delicate balance in the continuous cycle of ROS generation and inactivation is maintained by enzymatic and nonenzymatic endogenous systems. Overwhelming production of ROS (by such sources as the mitochondrial electron transport chain, NADPH oxidase, xanthine oxidase, or uncoupled nitric oxide synthase), when inadequately counteracted by destruction through antioxidant systems (such as superoxide dismutase or catalase), leads to a prooxidant state also known as oxidative stress. Increased levels of ROS and markers of oxidative stress have been consistently found in such cardiovascular diseases as atherosclerosis or hypertension, although controversy still exists over the pathophysiological role of oxidative stress in these conditions. ROS can modulate vascular function either by direct oxidative damage or by activating cellular signaling pathways that lead to abnormal contractile, inflammatory, proliferative, or remodeling properties of the blood vessel. Most current research focuses on these processes in arteries, leaving veins, "the other side" of vascular biology, in obscurity. Veins are different structurally and functionally from arteries. Equipped with a smaller smooth muscle layer compared to arteries, but being able to accommodate 70% of the circulating blood volume, veins can modulate cardiovascular homeostasis and contribute significantly to hypertension pathogenesis. Although the reports on the quantitative differences in ROS production in veins compared to arteries had conflicting results, there is a clear qualitative difference in ROS metabolism and utilization between the two vessel types. This review will compare and contrast the current knowledge of ROS metabolism in arteries versus veins in both physiological and pathophysiological conditions. Our understanding of the mechanisms underlying vascular diseases would greatly benefit from a more thorough exploration of the role of veins and venous oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202583

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  21 in total

Review 1.  Highly reactive oxygen species: detection, formation, and possible functions.

Authors:  Wolfhardt Freinbichler; Maria A Colivicchi; Chiara Stefanini; Loria Bianchi; Chiara Ballini; Bashkim Misini; Peter Weinberger; Wolfgang Linert; Damir Varešlija; Keith F Tipton; Laura Della Corte
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

2.  SeMet mediates anti-inflammation in LPS-induced U937 cells targeting NF-κB signaling pathway.

Authors:  Yue Shen; Shizhou Yang; Zhongli Shi; Tiao Lin; Hanxiao Zhu; Fanggang Bi; An Liu; Xiaozhou Ying; Haixiao Liu; Kehe Yu; Shigui Yan
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  Arterial vascular cell line expressing SSAO: a new tool to study the pathophysiology of vascular amine oxidases.

Authors:  Kaleem Ullah; Bingjie Xie; Javed Iqbal; Aamir Rasool; Hong Qing; Yulin Deng
Journal:  J Neural Transm (Vienna)       Date:  2013-04-02       Impact factor: 3.575

Review 4.  The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Authors:  Raymond Vanholder; Eva Schepers; Anneleen Pletinck; Evi V Nagler; Griet Glorieux
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

5.  A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase.

Authors:  Theodora Szasz; Janice M Thompson; Stephanie W Watts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

6.  Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension.

Authors:  Melissa Li; Xiaoling Dai; Stephanie Watts; David Kreulen; Gregory Fink
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-03       Impact factor: 3.619

7.  Divergent signaling mechanisms for venous versus arterial contraction as revealed by endothelin-1.

Authors:  Nathan R Tykocki; BinXi Wu; William F Jackson; Stephanie W Watts
Journal:  J Vasc Surg       Date:  2014-04-14       Impact factor: 4.268

8.  Impaired function of prejunctional adenosine A1 receptors expressed by perivascular sympathetic nerves in DOCA-salt hypertensive rats.

Authors:  Sutheera Sangsiri; Hua Dong; Gregory M Swain; James J Galligan; Hui Xu
Journal:  J Pharmacol Exp Ther       Date:  2013-02-08       Impact factor: 4.030

Review 9.  Redox signaling, vascular function, and hypertension.

Authors:  Moo Yeol Lee; Kathy K Griendling
Journal:  Antioxid Redox Signal       Date:  2008-06       Impact factor: 8.401

10.  A serotonergic system in veins: serotonin transporter-independent uptake.

Authors:  A Elizabeth Linder; Wei Ni; Theodora Szasz; Robert Burnett; Jessica Diaz; Timothy J Geddes; Donald M Kuhn; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2008-03-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.